| Literature DB >> 21871249 |
Johan S Bakken1, Thomas Borody, Lawrence J Brandt, Joel V Brill, Daniel C Demarco, Marc Alaric Franzos, Colleen Kelly, Alexander Khoruts, Thomas Louie, Lawrence P Martinelli, Thomas A Moore, George Russell, Christina Surawicz.
Abstract
Clostridium difficile infection is increasing in incidence, severity, and mortality. Treatment options are limited and appear to be losing efficacy. Recurrent disease is especially challenging; extended treatment with oral vancomycin is becoming increasingly common but is expensive. Fecal microbiota transplantation is safe, inexpensive, and effective; according to case and small series reports, about 90% of patients are cured. We discuss the rationale, methods, and use of fecal microbiota transplantation.Entities:
Mesh:
Year: 2011 PMID: 21871249 PMCID: PMC3223289 DOI: 10.1016/j.cgh.2011.08.014
Source DB: PubMed Journal: Clin Gastroenterol Hepatol ISSN: 1542-3565 Impact factor: 11.382